Search

Auritz

Auritz

rosuvastatin

Manufacturer:

Mega Lifesciences

Distributor:

Maxxcare
Concise Prescribing Info
Contents
Rosuvastatin Ca
Indications/Uses
As adjunctive therapy to diet to reduce elevated total-C, Apo-B, non-HDL & triglycerides & to increase HDL-C in adult w/ primary hyperlipidemia or mixed dyslipidemia; in ped patients 10-17 yr w/ heterozygous familial hypercholesterolemia. Adjunctive therapy to diet for the treatment of adult w/ hypertriglyceridemia. Adjunct to diet for the treatment of primary dysbetalipoproteinemia (type III hyperlipoproteinemia). Adjunctive therapy to other lipid-lowering treatment or alone in adult w/ homozygous familial hypercholesterolemia. Adjunctive therapy to diet to slow the progression of atherosclerosis in adult as part of a treatment strategy to lower total-C & LDL-C to target levels.
Click to view Auritz detailed prescribing information
Dosage/Direction for Use
Dose range: 5-40 mg once daily. Hyperlipidemia, mixed dyslipidemia, hypertriglyceridemia, primary dysbetalipoproteinemia (type III hyperlipoproteinemia) & slowing of the progression of atherosclerosis 10 mg once daily. Heterozygous familial hypercholesterolemia in ped patients (10-17 yr) 5-20 mg/day. Max: 20 mg/day. Adjustment dose at intervals of ≥4 wk. Homozygous familial hypercholesterolemia 20 mg. Use w/ cyclosporine or lopinavir/ritonavir 5 mg. Max: 10 mg. Concomitant lipid-lowering therapy 10 mg daily. Severe renal impairment 5 mg once daily. Max: 10 mg. All doses to be taken once daily.
Click to view Auritz detailed prescribing information
Overdosage
View Auritz overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Active liver disease. Pregnancy & lactation.
Click to view Auritz detailed prescribing information
Special Precautions
Patients w/ predisposing factors for myopathy. Perform liver enzyme tests prior to & periodically thereafter. Excessive alcohol consumption. Preexisting or history of chronic liver disease. Dose reduction for patients w/ unexplained persistent proteinuria &/or hematuria during routine urinalysis testing. Severe renal impairment. May impair ability to drive or operate machinery. Childn & elderly.
Click to view Auritz detailed prescribing information
Adverse Reactions
Rhabdomyolysis w/ myoglobinuria & acute renal failure & myopathy (including myositis); liver enzyme abnormalities. Headache, myalgia, abdominal pain, asthenia, nausea.
Click to view Auritz detailed prescribing information
Drug Interactions
Cyclosporin, gemfibrozil, lopinavir, ritonavir, coumarin anticoagulants, niacin, fenofibrate.
Click to view Auritz detailed prescribing information
Storage
View Auritz storage conditions for details to ensure optimal shelf-life.
Description
View Auritz description for details of the chemical structure and excipients (inactive components).
Action
View Auritz mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AA07 - rosuvastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Auritz FC tab 10 mg
Packing/Price
3 × 10's
Form
Auritz FC tab 20 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in